LADENBURG THALM/SH SH Cuts Core Scientific (NASDAQ:CORZ) Price Target to $23.75

Core Scientific (NASDAQ:CORZ) had its price objective trimmed by LADENBURG THALM/SH SH from $24.50 to $23.75 in a report released on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other brokerages have also recently commented on CORZ. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of Core Scientific in a report on Tuesday. Needham & Company LLC upgraded shares of Core Scientific from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Tuesday. Keefe, Bruyette & Woods upped their price objective on Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a report on Tuesday, January 27th. Sanford C. Bernstein lifted their price target on Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Finally, Citigroup upgraded Core Scientific from a “market perform” rating to an “outperform” rating in a research report on Thursday, December 18th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.84.

Core Scientific Stock Up 1.0%

Shares of CORZ stock opened at $16.00 on Tuesday. The firm has a market capitalization of $5.05 billion, a PE ratio of 13.68 and a beta of 6.87. The company has a 50 day moving average price of $17.28 and a 200-day moving average price of $16.95. Core Scientific has a 52 week low of $6.20 and a 52 week high of $23.63.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million for the quarter, compared to the consensus estimate of $118.45 million. Core Scientific’s quarterly revenue was down 16.0% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.69) earnings per share. Analysts anticipate that Core Scientific will post 0.52 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Allworth Financial LP boosted its holdings in Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after acquiring an additional 950 shares during the period. Larson Financial Group LLC lifted its position in shares of Core Scientific by 936.7% during the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares during the last quarter. HHM Wealth Advisors LLC boosted its stake in shares of Core Scientific by 96.5% during the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock valued at $33,000 after purchasing an additional 946 shares during the period. Osaic Holdings Inc. boosted its stake in shares of Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after purchasing an additional 1,066 shares during the period. Finally, Danske Bank A S bought a new position in shares of Core Scientific in the fourth quarter worth about $36,000.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
• Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
• Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
• Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
• Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
• Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
• Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.